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Compared with patients with heart failure and reduced ejection 
fraction (HeFREF), patients with heart failure and normal ejection 
fraction (HeFNEF) are older, more likely to be female, have a higher 
prevalence of hypertension and anemia, and a lower prevalence of 
coronary artery disease (Olsson et al., 2006; Senni et al., 1998; Yap 
et al., 2015).
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Background: Little is known about ECG abnormalities in patients with heart failure 
and normal ejection fraction (HeFNEF) and how they relate to different etiologies or 
outcomes.
Methods  and  Results: We searched the literature for peer‐reviewed studies de‐
scribing ECG abnormalities in HeFNEF other than heart rhythm alone. Thirty five 
studies	were	identified	and	32,006	participants.	ECG	abnormalities	reported	in	pa‐
tients with HeFNEF include atrial fibrillation (prevalence 12%–46%), long PR inter‐
val	(11%–20%),	left	ventricular	hypertrophy	(LVH,	10%–30%),	pathological	Q	waves	
(11%–18%),	 RBBB	 (6%–16%),	 LBBB	 (0%–8%),	 and	 long	 JTc	 (3%–4%).	Atrial	 fibrilla‐
tion is more common in patients with HeFNEF compared to those with heart failure 
and	reduced	ejection	fraction	(HeFREF).	In	contrast,	long	PR	interval,	LVH,	Q	waves,	
LBBB, and long JTc are more common in patients with HeFREF. A pooled effect esti‐
mate	analysis	showed	that	QRS	duration	≥120	ms,	although	uncommon	(13%–19%),	
is associated with worse outcomes in patients with HeFNEF.
Conclusions: There is high variability in the prevalence of ECG abnormalities in pa‐
tients with HeFNEF. Atrial fibrillation is more common in patients with HeFNEF 
compared	 to	 those	with	HeFREF.	QRS	duration	≥120	ms	 is	associated	with	worse	
outcomes in patients with HeFNEF. Further studies are needed to address whether 
ECG abnormalities correlate with different phenotypes in HeFNEF.
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ECG abnormalities in HeFREF are widely described and guide 
medical and device therapy. However, many studies in HeFNEF do 
not report ECG characteristics other than heart rhythm. Hence, 
other than a high prevalence of atrial fibrillation, little is known about 
ECG features associated with HeFNEF. In recent years, attempts 
have been made to identify different phenotypic groups among pa‐
tients with HeFNEF based on comorbidities, such as hypertension, 
obesity, or lung disease, in order to target therapeutic interventions 
and predict outcomes (Gorter et al., 2018; Shah et al., 2015). ECG 
variables may provide an additional noninvasive tool to help identify 
distinct phenotypes with different trajectories.
2  | METHODS
2.1 | Search strategy and selection criteria
We identified peer‐reviewed studies published in English in patients 
with HeFNEF describing ECG variables other than heart rhythm 
alone. Participants included were men and women with a diagnosis 
of HeFNEF. We included the following types of studies performed in 
any healthcare setting:
1. Randomized controlled trials (RCTs)
2. Controlled trials
3.	 Observational	studies	with	the	following	designs:
a. Single‐gate design (all participants had HeFNEF)
b. Two‐gate design (the same study includes participants with 
and without HeFNEF)
We excluded the following:
1. Studies without information on recruitment methods or study 
population
2. Case reports or case series
3.	 Studies	reported	only	in	abstract	form	or	in	conference	proceed‐
ings where the full text was not available.
We searched the following databases to identify the published stud‐
ies that reported ECG variables in patients with HeFNEF (inception 
to January 2019): CENTRAL, MEDLINE, EMBASE, CINAHL, Web of 
Science, LILACS, and TRIP. We also searched databases of trial regis‐
tries and hand‐searched the reference list of all relevant publications.
2.2 | Data collection and analysis
We examined abstracts and excluded duplicates, review articles, 
and articles reporting imaging and ECG variables alone without 
baseline clinical characteristics of heart failure (Figure 1). We also 
excluded studies of nonrepresentative cohorts, such as those with 
high prevalence of valvular heart disease, in order to minimize the 
risk of bias (Appendix I). Two review authors (TN and NS) inde‐
pendently assessed the full‐text publication of the remaining arti‐
cles. Disagreements were resolved by a third reviewer (ALC). The 
process of study selection was documented in accordance with 
the Preferred Reporting Items for Systematic Reviews and Meta‐
Analyses (PRISMA; Figure 1).
2.3 | Statistical analysis
A pooled prevalence of right bundle branch block in HeFNEF and 
confidence intervals for individual studies were estimated using the 
Metaprop function (STATA‐SE 14) using a random effects model and 
the Clopper–Pearson exact confidence intervals method (Nyaga, 
Arbyn, & Aerts, 2014). Between‐study heterogeneity was statisti‐
cally assessed by calculating an I2 and chi‐square.
Where studies compared adverse outcomes between patients 
with	 and	 without	 prolonged	 QRS/bundle	 branch	 block,	 a	 pooled	
effect	 estimate	 of	 abnormal	 QRS	 was	 estimated.	 Analysis	 was	
completed	using	Review	Manager	5.3,	and	a	random	effects	model	




The literature review identified 219 studies. After reviewing the ab‐
stracts, 94 studies were excluded and a further 46 were excluded 
after	 reviewing	 full‐text	 articles	 (Figure	1;	Appendix	 I);	 35	 studies	
were included in the final review (Table 1). When multiple reports 
from the same cohort were published the report, most representa‐
tive of ECG variables was included (Table 2).
The definition of HeFNEF varied among studies (Appendix II). 
In addition, different cutoffs for left ventricular ejection fraction 
(LVEF)	were	 used	 to	 define	HeFNEF:	 ≥40%	 (Cenkerova,	Dubrava,	
Pokorna, Kaluzay, & Jurkovicova, 2016; Danciu et al., 2006; Hendry, 
Krisdinarti, & Erika, 2016), >40% (Hawkins et al., 2007; Olsson et 
al.,	 2006),	 ≥45%	 (Adabag	 et	 al.,	 2014;	 Donal	 et	 al.,	 2014;	 Joseph	
et al., 2016; Komajda et al., 2011; Nikolaidou et al., 2017; Shah et 
al.,	2013),	>45%	(Ho	et	al.,	2013;	Lee	et	al.,	2009;	Park	et	al.,	2013;	
Zile	et	al.,	2011),	≥50%	(Gigliotti	et	al.,	2017;	Gijsberts	et	al.,	2016;	
Hummel, Skorcz, & Koelling, 2009; Khan et al., 2007; Lund et al., 
2013;	Martinez	 Santos	 et	 al.,	 2016;	Masoudi	 et	 al.,	 2003;	Menet	
et al., 2014; O'Neal et al., 2017; Pascual‐Figal et al., 2017; Peyster, 
Norman, & Domanski, 2004; Senni et al., 1998; Shenkman et al., 
2002; Yap et al., 2015), >50% (Eicher et al., 2012; Oskouie, Prenner, 
Shah, & Sauer, 2017; Sanchis et al., 2015; Selvaraj et al., 2014; Shah 
et	 al.,	 2015),	 and	 ≥55%	 (Varadarajan	 &	 Pai,	 2003).	 The	 following	
methods were used to measure ejection fraction: echocardiogra‐
phy, nuclear scintigraphy, and contrast ventriculography. Six stud‐
ies included patients with heart failure and valvular heart disease 
(3%–20%	of	 patients	with	HeFNEF)	 (Donal	 et	 al.,	 2014;	Ho	 et	 al.,	
2013;	Lee	et	al.,	2009;	Lund	et	al.,	2013;	Park	et	al.,	2013;	Peyster	
et al., 2004).
Three studies assessed the risk of future heart failure asso‐
ciated with baseline ECG characteristics in populations without 
heart failure at baseline (suspected coronary ischemia (O'Neal et 
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al.,	2017)	and	the	general	population	 (Ho	et	al.,	2013;	Lee	et	al.,	
2009)).
Two studies provided ECG characteristics specifically in pa‐
tients with heart failure and mid‐range ejection fraction 40%–49% 
(HeFmrEF)	(Lund	et	al.,	2013;	Pascual‐Figal	et	al.,	2017).
3.2 | Participants
A	 total	 of	 32,006	 participants	 with	 HeFNEF	 were	 included.	 The	
mean age was 74 years, and 56% were women. Participant comor‐
bidities are summarized in Appendix II.
3.3 | Atrial fibrillation
In the studies we identified, the prevalence of atrial fibrillation or 
atrial flutter on ECG was 12%–46% (Adabag et al., 2014; Cenkerova 
et	al.,	2016;	Donal	et	al.,	2014;	Ho	et	al.,	2013;	Khan	et	al.,	2007;	Lee	
et	al.,	2009;	Masoudi	et	al.,	2003;	Nikolaidou	et	al.,	2017;	Olsson	et	
al., 2006; Oskouie et al., 2017; Pascual‐Figal et al., 2017; Peyster et 
al., 2004; Sanchis et al., 2015; Selvaraj et al., 2014; Senni et al., 1998; 
Shah	et	al.,	2013;	Yap	et	al.,	2015).	The	percentage	of	patients	with	
a history of atrial fibrillation (where reported) was greater (Lee et 
al.,	2009;	Shah	et	al.,	2013).	 In	 the	studies	 including	patients	with	
HeFREF,	 the	prevalence	of	 atrial	 fibrillation	was	 lower	 (15%–36%)	
in HeFREF than in HeFNEF (16%–46%) (Cenkerova et al., 2016; 
Hawkins	 et	 al.,	 2007;	 Nikolaidou	 et	 al.,	 2017;	 Park	 et	 al.,	 2013;	
Pascual‐Figal et al., 2017; Peyster et al., 2004; Senni et al., 1998; Yap 
et al., 2015). Only one study (of 2,258 patients admitted with heart 
failure) found a higher prevalence of atrial fibrillation in patients with 
reduced	ejection	fraction	(26%	vs.	20%)	(Varadarajan	&	Pai,	2003).
In the CHARM program, 7,599 patients with heart failure and 
NYHA class symptoms II‐IV were randomized to candesartan or pla‐
cebo	and	 followed	up	 for	38	months.	3,023	patients	had	HeFNEF	
(ejection fraction > 40%) and 478 (16%) of these had atrial fibrillation 
at baseline. The presence of atrial fibrillation at baseline was an in‐
dependent risk factor for cardiovascular death or hospitalization for 
heart	failure	and	all‐cause	mortality	after	adjusting	for	32	covariates	
(Olsson et al., 2006).
3.4 | P/PR duration
First‐degree	 AV	 block	 (PR	 ≥	 200	 ms)	 was	 present	 in	 11%–21%	
of patients with HeFNEF (Donal et al., 2014; Khan et al., 2007; 
Nikolaidou et al., 2017) but was more common in patients with 
HeFREF (21%–26%) (Khan et al., 2007; Nikolaidou et al., 2017). 
In	a	prospective	observational	study	of	539	patients	admitted	to	
hospital with clinical signs of heart failure and LVEF > 45%, 11% 
had 1st‐degree heart block (Donal et al., 2014). Higher degree 
F I G U R E  1   PRISMA flowchart
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atrioventricular block (second or third) was present in 2%–6% 
of patients with HeFNEF in the I‐PRESERVE trial (Adabag et al., 
2014).
In	a	population	of	3,664	referred	to	a	community	clinic	with	sus‐
pected heart failure, 20% of 1,094 patients with HeFNEF and 21% of 
1,420 with HeFREF had first‐degree heart block (as did 9% of those 
without heart failure) (Nikolaidou et al., 2017). Among patients with 
HeFNEF	 and	QRS	 ≥	 130	ms,	 the	 prevalence	 of	 first‐degree	 heart	
block was even higher (40%).
Twenty‐seven patients with HeFNEF requiring hospitalization 
and 27 controls (outpatients referred for echocardiography or with 
stable coronary disease or mild valve disease but no HeFNEF) un‐
derwent ECG and echocardiographic assessment. Patients with 
HeFNEF had longer P waves and shorter echocardiographic A waves 
(Eicher et al., 2012).
3.5 | QRS
Left bundle branch block (LBBB) is present in up to 50% of pa‐
tients with HeFREF(Danciu et al., 2006; Khan et al., 2007; Lund 
et	al.,	2013;	Senni	et	al.,	1998;	Varadarajan	&	Pai,	2003)	but	only	
0%–8% of patients with HeFNEF (Donal et al., 2014; Khan et 
al., 2007; Komajda et al., 2011; Lee et al., 2009; Masoudi et al., 
2003;	Menet	et	al.,	2014;	Peyster	et	al.,	2004;	Shah	et	al.,	2013;	
Varadarajan	&	Pai,	2003).	Right	bundle	branch	block	(RBBB)	is	pre‐
sent in 5%–11% of patients with HeFREF (weighted average 7%) 
(Donal et al., 2014; Khan et al., 2007; Lee et al., 2009; Shah et al., 
2013;	 Varadarajan	 &	 Pai,	 2003)	 and	 in	 6%–16%	 (weighted	 aver‐
age 9%) of patients with HeFNEF (Figure 2a) (Danciu et al., 2006; 
Donal et al., 2014; Hendry et al., 2016; Khan et al., 2007; Lee et 
al., 2009; Martinez Santos et al., 2016; Pascual‐Figal et al., 2017; 
Selvaraj	et	al.,	2014;	Varadarajan	&	Pai,	2003).	RBBB	is	more	com‐
mon in patients with HeFNEF compared to HeFREF but without 
reaching statistical significance due to limited data available.
In	an	analysis	of	the	CHARM	trials,	which	included	3,023	patients	







patients referred with suspected heart failure reported that 5% of 
1,107	patients	with	HeFNEF	had	QRS	≥	150	ms	versus	18%	of	those	
with HeFREF (Nikolaidou et al., 2017).
Increasing	QRS	 duration	 (especially	with	 LBBB	morphology)	 is	
associated with increased mortality in HeFREF (Shamim et al., 1999). 
Conflicting results have been reported in patients with HeFNEF. In 
a study of 25,171 patients from the SwedeHF registry, increasing 
QRS	duration	was	an	independent	risk	factor	for	increasing	all‐cause	
mortality	regardless	of	ejection	fraction	(Lund	et	al.,	2013).	An	anal‐
ysis of the TOPCAT trial showed that the risk of heart failure hos‐
pitalization was significantly higher in patients with HeFNEF and 
QRS	≥	120	ms	(Joseph	et	al.,	2016).	Another	study	of	872	patients	
admitted to Michigan community hospitals with HeFNEF reported 
that	QRS	duration	>120	ms	on	a	predischarge	ECG	was	an	indepen‐
dent predictor of postdischarge death (Hummel et al., 2009).
Increasing	 QRS	 duration	 was	 an	 independent	 predictor	 of	 in‐
creasing 2‐year cardiovascular mortality but not all‐cause mortality 
in an Asian population with heart failure and ejection fraction >50% 
(Yap et al., 2015). In a retrospective study of 108 patients admitted 
with HeFNEF, the presence of intraventricular conduction defects 
with	QRS	>	120	ms	was	associated	with	higher	180‐day	readmission	
and mortality rates (adjusted for age) compared to patients with nar‐
rower	QRS	(Danciu	et	al.,	2006).
In contrast, in the CHARM trials, the presence of bundle branch 
block increased the risk of the primary outcome of cardiovascu‐
lar death or unplanned hospital admission for heart failure only 
in patients with HeFREF and not those with HeFNEF (Hawkins et 
al., 2007). Similarly, in the REACH (Resource Utilization Among 
Congestive	Heart	Failure)	study	of	3,471	patients	with	heart	failure,	
1,811 of whom had normal ejection fraction (LVEF > 45%), longer 
QRS	duration	was	again	only	associated	with	worse	survival	in	pa‐
tients with HeFREF (Shenkman et al., 2002).
In	 an	 observational	 study	 of	 2,913	 inpatients	 and	 outpatients	
with heart failure (Singaporean Asian patients from the SHOP co‐
hort	 and	 Swedish	 patients	 in	 the	 SwedeHF	 Registry),	 longer	QRS	
increased the composite risk of heart failure hospitalization or death 
in patients with HeFREF but not HeFNEF (Gijsberts et al., 2016). 
The difference between this report and the main SwedeHF registry 
(Lund	et	al.,	2013)	may	reflect	the	fact	that	this	study	was	designed	
to assess differences between Singaporean and Swedish cohorts. 
Only the subset of patients from SwedeHF enrolled after 2009 was 
included (fewer than half of the total cohort), limiting statistical 
power, and the patients were followed for a much shorter period of 
time than in the main study.
In another observational study of 1,107 outpatients with HeFNEF 
followed	up	in	the	heart	failure	clinic	for	3.7	years,	QRS	duration	was	
associated with worse survival in univariable analysis but not when 
corrected for other variables (increasing log[NT‐ProBNP], male sex, 
higher New York Heart Association class, age and a faster baseline 
heart rate) (Nikolaidou et al., 2017). A report from the prospective 
Korean Acute Heart Failure Registry of patient admitted with heart 
failure	showed	that	increasing	QRS	duration	was	not	associated	with	
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all‐cause mortality and heart failure hospitalization in patients with 
HeFNEF	(Park	et	al.,	2013).
We	were	 able	 to	 pool	 outcome	 data	 associated	with	QRS	 du‐
ration in patients with HeFNEF from five studies (Figure 2b), 




was 11%–18% (Hendry et al., 2016; Khan et al., 2007; Shah et al., 
2013).	In	a	study	of	137	patients	with	a	new	diagnosis	of	heart	fail‐
ure, 15% of those with HeFNEF and 42% of those with HeFREF 




cardial infarction on ECG (compared with 60% of those with reduced 
ejection	fraction)	(Varadarajan	&	Pai,	2003).
3.7 | Ventricular repolarization
Prolonged ventricular repolarization is associated with ventricular 
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The JTc interval was longer in 1,107 patients with HeFNEF in 
an outpatients clinic compared to 1,155 patients in the same clinic 
found not to have heart failure (p = .01). However, abnormal dura‐
tion	of	repolarization	is	uncommon	in	HeFNEF	with	4.3%	of	patients	
with HeFNEF having severe JTc interval prolongation (>400 ms) 
compared to 4.7% of those without heart failure (Nikolaidou et al., 
2017).	Similarly,	 the	prevalence	of	 JTc	>	400	ms	among	5,934	pa‐
tients hospitalized with a suspected diagnosis of heart failure (ex‐
cluding	patients	with	ventricular	pacing)	was	3.1%	in	patients	with	
no echocardiographic abnormality and 2.8% in those with echocar‐
diographic evidence to support a diagnosis of HeFNEF (Khan et al., 
2007) In these studies, the prevalence of JTc > 400 ms in patients 
with HeFREF was 4%–8% (Khan et al., 2007; Nikolaidou et al., 2017).
In	an	observational	study	of	376	outpatients	with	HeFNEF,	 in‐
creasing	 frontal	 QRS‐T	 angle	 was	 independently	 associated	 with	
higher B‐type natriuretic peptide (BNP) level, worse left ventricu‐
lar diastolic function and worse right ventricular systolic function. 
Increasing	QRS‐T	angle	was	also	independently	associated	with	an	
increase in the composite outcome of cardiovascular hospitalization 
even after adjusting for BNP (Selvaraj et al., 2014).
3.8 | Left ventricular hypertrophy (LVH)
The prevalence of electrocardiographic evidence of LVH in studies 
of	 patients	with	HeFNEF	 ranges	 between	 10%	 and	 30%	 (Hendry	
et al., 2016; Khan et al., 2007; Komajda et al., 2011; Senni et al., 
1998;	Shah	et	al.,	2013).	LVH	may	be	more	common	in	patients	with	
HeFREF (Hendry et al., 2016; Senni et al., 1998). In six studies where 
information was available (Adabag et al., 2014; Hawkins et al., 2007; 
Komajda	et	al.,	2011;	Olsson	et	al.,	2006;	Shah	et	al.,	2013),	criteria	
used to define LVH included the Sokolow‐Lyon (Antikainen et al., 
2003),	Cornell	(Casale,	Devereux,	Alonso,	Campo,	&	Kligfield,	1987),	
and Estes criteria (Romhilt & Estes, 1968).
3.9 | Multivariable models
A cross‐sectional ECG study of 110 inpatients and outpatients with 
chronic heart failure in sinus rhythm at a single centre (50 with 
HeFNEF and EF > 40%) identified ECG variables that helped distin‐
guish patients with HeFREF from those with HeFNEF. Those with 
HeFREF	were	more	likely	to	have	left	atrial	hypertrophy,	QRS	dura‐
tion >100 ms, LBBB, absence of RBBB, ST‐T segment changes, and 
QT	interval	prolongation.	A	model	including	all	these	variables	sepa‐
rated the two conditions with 96% specificity and 76% sensitivity 
(Hendry et al., 2016).
In	 534	 participants	 with	 new‐onset	 heart	 failure	 from	 the	
Framingham	heart	study,	those	with	HeFREF	(LVEF	≤	45%)	were	less	
likely to have atrial fibrillation and more likely to have LBBB and a 
faster heart rate at heart failure onset compared to patients with 
HeFNEF in multivariable analysis (Lee et al., 2009).
In an analysis of the Irbesartan in Heart Failure with Preserved 
Ejection Fraction Study (I‐PRESERVE), four ECG variables (heart 
rate, LVH, LBBB, and atrial fibrillation/flutter) were included among 
58 variables in a multivariable model for predicting morbidity and 
mortality. Only a faster heart rate was an independent predictor of 
all‐cause mortality (Komajda et al., 2011).
A	study	of	397	patients	with	HeFNEF	previously	hospitalized	for	
heart failure used 67 variables (including six ECG variables) and model‐
based clustering to describe distinct phenotypes among patients with 
HeFNEF (Shah et al., 2015). Phenogroup 1 included younger patients 
with fewer symptoms and lower BNP, as well as fewer ECG and echo‐
cardiographic abnormalities. Phenogroup 2 had the highest preva‐
lence	of	obesity,	diabetes,	and	COPD.	Phenogroup	3	patients	were	
older with higher BNP and higher prevalence of CKD and with the lon‐
gest	PR,	QRS	and	QTc	duration	as	well	as	greatest	QRS‐T	angle	com‐
pared	to	other	groups.	Phenogroup	classification	1–3	was	associated	
with a step‐wise increase in the risk of heart failure hospitalization, 
cardiovascular hospitalization, or death even after adjusting for BNP.
3.10 | Risk of developing future heart failure
In	a	study	of	6,340	participants	from	the	Framingham	Heart	Study	
followed for 10 years, 196 developed HeFNEF and 261 HeFREF. 
There were 14 predictors of incident heart failure. Higher body mass 
index, smoking, and atrial fibrillation predicted HeFNEF only, while 
male sex, higher cholesterol, higher heart rate, hypertension, cardio‐
vascular	disease,	LVH,	and	LBBB	predicted	HeFREF	(Ho	et	al.,	2013).	
The MESA (Multi‐Ethnic Study of Atherosclerosis) study followed 
6,664 participants free from cardiovascular disease at baseline for 
a median of 12 years. Higher resting heart rate, abnormal P‐wave 
axis,	and	abnormal	QRS‐T	axis	were	 independent	predictors	of	fu‐
ture HeFNEF (O'Neal et al., 2017).
4  | DISCUSSION
We have found that atrial fibrillation is more common in patients 
with HeFNEF compared to those with HeFREF. RBBB is also more 
common in patients with HeFNEF. In contrast, long PR interval, LVH, 
Q	waves,	 LBBB,	 and	 long	 JTc	 are	more	 common	 in	 patients	 with	
HeFREF. Therefore, a combination of variables, such as the presence 
of atrial fibrillation and the absence of LBBB, may help differenti‐
ate patients with HeFNEF compared to those with HeFREF, when 
echocardiography is not immediately available or in patients with 
mid‐range left ventricular function.
There is high variability in the prevalence of ECG abnormalities 
among the included studies. This is likely to reflect different popu‐
lations with different characteristics. There may well be substantial 
differences between, for example, inpatient and outpatient cohorts, 
and differences depending upon disease etiology and severity, and 
differences depending upon the variable prevalence of comorbid‐
ities such as COPD and hypertension. Different diagnostic criteria 
and analysis methods used for interpretation of ECG variables may 
be a further source of variability. In addition, electrocardiographic 
intervals can change over time and with treatment and few studies 
have reported serial measurements.
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Only two studies specifically discussed patients with HeFmrEF 
(LVEF 40%–49%). The data we have found cannot fully address the 
subject of ECG changes in HeFmrEF, particularly given the different 
boundary definitions of LVEF in the studies we found. In one study 
comparing	patients	across	the	three	ejection	fraction	groups,	QRS	
duration as well as the prevalence of atrial fibrillation, and LBBB and 
RBBB were intermediate between those of patients with HeFNEF 
and HeFREF in patients with HeFmrEF.
Hypertension is the commonest cause of HeFNEF. LVH is one of 
the diagnostic criteria for HeFNEF (Ponikowski et al., 2016a) and is as‐
sociated with worse outcomes (Zile et al., 2011). Electrocardiographic 
LVH is a strong predictor of diastolic dysfunction and treatment of hy‐
pertension results in regression of electrocardiographic LVH (Krepp, 
Lin, Min, Devereux, & Okin, 2014). In an analysis of the I‐PRESERVE 
trial, LVH was present in 59% of patients with HeFNEF using echo‐
cardiographic criteria and 28% using ECG criteria (Zile et al., 2011). 
The overall prevalence of electrocardiographic LVH in patients with 
HeFNEF	included	in	this	review	was	10%–30%.
Right ventricular systolic dysfunction as a consequence of 
increased pulmonary artery pressure is common in HeFNEF. It is 
present in at least one‐fifth of patients with HeFNEF and is asso‐
ciated with worse prognosis (Gorter et al., 2018; Martinez Santos 
et al., 2016). Right heart failure is a common mode of death in 
patients with HeFNEF (Aschauer et al., 2017). 9% of patients with 
HeFNEF have RBBB and a proportion of these patients may have 
lung disease and/or right heart failure contributing to their symp‐
toms, consistent with phenogroup 2 features (Shah et al., 2015). 
The prevalence of COPD/lung disease in the studies included in 
this review was 12%–40%.
Left atrial enlargement is one of the hallmarks of HeFNEF 
(Ponikowski et al., 2016a) and is associated with atrial fibrillation and 
worse outcomes (Zile et al., 2011). Only two studies have reported 
electrocardiographic P‐wave duration in patients with HeFNEF. PR 
interval duration is prolonged in patients with HeFNEF compared to 
patients without heart failure, which may at least partly reflect atrial 
enlargement. In the absence of symptoms, an abnormal P‐wave axis 
is independently associated with future HeFNEF (O'Neal et al., 2017).
Clinical variables known to be associated with worse all‐cause 
mortality in HeFNEF include older age and the presence of renal 
impairment, lower blood pressure, anemia, history of stroke, or de‐
mentia (Nikolaidou et al., 2017; Yap et al., 2015). Our analysis shows 
that	QRS	duration	≥	120	ms	 is	a	risk	factor	associated	with	worse	
outcomes in patients with HeFNEF.
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APPENDIX I
Studies excluded Reason for exclusion
(Tanoue, Kjeldsen, Devereux, & 
Okin, 2017)
No heart failure symptoms
(van Boven et al., 1998) No heart failure symptoms
(Ofman et al., 2012) No heart failure symptoms
((Murkofsky et al., 1998) No heart failure symptoms
(Okin, Wachtell, Gerdts, 
Dahlof, & Devereux, 2014)
No heart failure symptoms
(Triola et al., 2005) No heart failure symptoms
(Onoue et al., 2016) No heart failure symptoms
(Sauer et al., 2012) No heart failure symptoms
(Namdar	et	al.,	2013) No heart failure symptoms
(Basnet, Manandhar, Shrestha, 
Shrestha, & Thapa, 2009)
No heart failure symptoms
(Nielsen, Hansen, Hilden, 
Larsen, & Svanegaard, 2000)
No heart failure symptoms
(Okin et al., 2001) No heart failure symptoms
(Mewton et al., 2016) No heart failure symptoms, non‐
representative population
(Wachtell et al., 2007) No heart failure symptoms
(Wilcox, Rosenberg, Vallakati, 
Gheorghiade, & Shah, 2011)
No heart failure symptoms
(Sartipy, Dahlstrom, Fu, & 
Lund, 2017)
No ECG data other than heart 
rhythm
(West et al., 2011) No ECG data other than heart 
rhythm
(Zakeri, Chamberlain, Roger, & 
Redfield,	2013)
No ECG data other than heart 
rhythm
(Eapen et al., 2014) No ECG data other than heart 
rhythm
(Brouwers	et	al.,	2013) No ECG data other than heart 
rhythm
(Perez de Isla et al., 2008) No ECG data other than heart 
rhythm
(Martin, 2007) No ECG data other than heart 
rhythm
(Gotsman et al., 2008) No ECG data other than heart 
rhythm
Studies excluded Reason for exclusion
(Goda et al., 2010) No ECG data other than heart 
rhythm
(Zhang, Liebelt, Madan, 
Shan, & Taub, 2017)
No ECG data other than heart 
rhythm
(Cleland et al., 2006) No ECG data other than heart 
rhythm
(Ahmed et al., 2006) No ECG data other than heart 
rhythm
(Yusuf	et	al.,	2003) No ECG data other than heart 
rhythm
(Quiroz	et	al.,	2014) No ECG data other than heart 
rhythm
(Phan et al., 2010) No ECG data other than chrono‐
tropic incompetence
(Arora et al., 2004) No ECG data other than chrono‐
tropic incompetence
(De Sutter et al., 2005) Echocardiographic study of ven‐
tricular dyssynchrony
(Wang, Kurrelmeyer, Torre‐
Amione, & Nagueh, 2007)
Echocardiographic study of ven‐
tricular dyssynchrony
(Oluleye et al., 2014) Overlapping analyses of same data
(McMurray et al., 2008) Overlapping analyses of same data
(Selvaraj et al., 2018) Overlapping analyses of same data
(Santhanakrishnan et al., 2016) Overlapping analyses of same data
(Silverman et al., 2016) Overlapping analyses of same data
(Okin et al., 2007) No distinction of heart failure 
subtype
(Mureddu et al., 2012) No distinction of heart failure 
subtype
(McCullough et al., 2005) HeFREF only
(Shamim et al., 1999) HeFREF only
(Karaye & Sani, 2008) Nonrepresentative population
(Park et al., 2012) Nonrepresentative population
(Beladan et al., 2014) Nonrepresentative population
(Bauer et al., 2009) Nonrepresentative population
A P P E N D I X  I   (Continued)
(Continues)
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